NO993385L - Transdermalt terapeutisk system for avgivelse av hormoner - Google Patents
Transdermalt terapeutisk system for avgivelse av hormonerInfo
- Publication number
- NO993385L NO993385L NO993385A NO993385A NO993385L NO 993385 L NO993385 L NO 993385L NO 993385 A NO993385 A NO 993385A NO 993385 A NO993385 A NO 993385A NO 993385 L NO993385 L NO 993385L
- Authority
- NO
- Norway
- Prior art keywords
- hormones
- release
- therapeutic system
- transdermal therapeutic
- active compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Virkestoffholdig plaster for kontrollert avgivelse av østradiol eller dens farmasøytisk godtagbare derivater, alene eller i kombinasjon med gestagener, på den menneskelige eller animalske hud, med et virkestoflholdig reservoar på basis av etylcellulose og klebeharpiks oppvisende hefteklebemidler, er kjennetegnet ved et hefteklebemiddel med høy andel av mykgjører.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19700913A DE19700913C2 (de) | 1997-01-14 | 1997-01-14 | Transdermales therapeutisches System zur Abgabe von Hormonen |
PCT/EP1998/000014 WO1998031349A1 (de) | 1997-01-14 | 1998-01-03 | Transdermales therapeutisches system zur abgabe von hormonen |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993385D0 NO993385D0 (no) | 1999-07-08 |
NO993385L true NO993385L (no) | 1999-07-08 |
Family
ID=7817287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993385A NO993385L (no) | 1997-01-14 | 1999-07-08 | Transdermalt terapeutisk system for avgivelse av hormoner |
Country Status (11)
Country | Link |
---|---|
US (1) | US6274165B1 (no) |
EP (1) | EP1007014B1 (no) |
JP (1) | JP3821855B2 (no) |
KR (1) | KR100561255B1 (no) |
AT (1) | ATE238778T1 (no) |
AU (1) | AU729494B2 (no) |
CA (1) | CA2276445C (no) |
DE (2) | DE19700913C2 (no) |
ES (1) | ES2201434T3 (no) |
NO (1) | NO993385L (no) |
WO (1) | WO1998031349A1 (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19830651A1 (de) * | 1998-07-09 | 2000-01-13 | Lohmann Therapie Syst Lts | Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung |
ES2204732T3 (es) * | 1999-11-29 | 2004-05-01 | Lts Lohmann Therapie-Systeme Ag | Sistemas terapeuticos transdermicos con estabilidad mejorada y un procedimiento para su preparacion. |
DE10054713C2 (de) * | 1999-11-29 | 2002-07-18 | Lohmann Therapie Syst Lts | Transdermale Therapeutische Systeme mit verbesserter Stabilität und ein Verfahren zu ihrer Herstellung |
AU3104301A (en) | 2000-01-20 | 2001-07-31 | Noven Pharmaceuticals, Inc. | Compositions and methods to effect the release profile in the transdermal administration of active agents |
DE10025970C2 (de) * | 2000-05-25 | 2002-04-25 | Lohmann Therapie Syst Lts | Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung |
WO2005030176A1 (en) | 2003-09-29 | 2005-04-07 | Novo Nordisk Femcare Ag | Improved stability of progestogen formulations |
HU227970B1 (en) | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
AU2012332254B2 (en) * | 2011-11-04 | 2017-06-22 | Agile Therapeutics, Inc. | Dermal delivery compositions and methods |
WO2013078422A2 (en) | 2011-11-23 | 2013-05-30 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
AU2013211876B2 (en) * | 2012-01-26 | 2017-02-09 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2015179782A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4906169A (en) * | 1986-12-29 | 1990-03-06 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
CN1021196C (zh) | 1986-12-29 | 1993-06-16 | 新泽西州州立大学(鲁杰斯) | 透皮雌激素/孕激素药剂单元、系统及方法 |
DE3743945A1 (de) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung |
US4994267A (en) * | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
DE3933460A1 (de) | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
DE4020144A1 (de) * | 1990-06-25 | 1992-01-09 | Lohmann Therapie Syst Lts | Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen |
US5158734A (en) * | 1991-02-27 | 1992-10-27 | Minnesota Mining And Manufacturing Company | Biomedical electrical connector using a socket receptacle having a resilient sheath |
DE4230588C1 (de) * | 1992-09-12 | 1993-10-07 | Lohmann Therapie Syst Lts | Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung |
DE4333595A1 (de) * | 1993-10-01 | 1995-04-06 | Labtec Gmbh | Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut |
FR2717689B1 (fr) * | 1994-03-28 | 1996-07-05 | Lhd Lab Hygiene Dietetique | Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène. |
FR2717688B1 (fr) * | 1994-03-28 | 1996-07-05 | Lhd Lab Hygiene Dietetique | Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA. |
KR100209469B1 (ko) * | 1994-10-05 | 1999-07-15 | 나까도미 히로다카 | N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형 제제 |
DE19500662C2 (de) * | 1995-01-12 | 2001-04-26 | Lohmann Therapie Syst Lts | Estradiolhaltiges Pflaster und seine Verwendung |
-
1997
- 1997-01-14 DE DE19700913A patent/DE19700913C2/de not_active Expired - Fee Related
-
1998
- 1998-01-03 WO PCT/EP1998/000014 patent/WO1998031349A1/de not_active Application Discontinuation
- 1998-01-03 AU AU57654/98A patent/AU729494B2/en not_active Ceased
- 1998-01-03 ES ES98901337T patent/ES2201434T3/es not_active Expired - Lifetime
- 1998-01-03 KR KR1019997006404A patent/KR100561255B1/ko not_active IP Right Cessation
- 1998-01-03 AT AT98901337T patent/ATE238778T1/de not_active IP Right Cessation
- 1998-01-03 EP EP98901337A patent/EP1007014B1/de not_active Expired - Lifetime
- 1998-01-03 CA CA002276445A patent/CA2276445C/en not_active Expired - Fee Related
- 1998-01-03 US US09/341,212 patent/US6274165B1/en not_active Expired - Fee Related
- 1998-01-03 JP JP53137798A patent/JP3821855B2/ja not_active Expired - Fee Related
- 1998-01-03 DE DE59808186T patent/DE59808186D1/de not_active Expired - Lifetime
-
1999
- 1999-07-08 NO NO993385A patent/NO993385L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE19700913A1 (de) | 1998-07-16 |
ES2201434T3 (es) | 2004-03-16 |
DE59808186D1 (de) | 2003-06-05 |
AU729494B2 (en) | 2001-02-01 |
US6274165B1 (en) | 2001-08-14 |
EP1007014B1 (de) | 2003-05-02 |
AU5765498A (en) | 1998-08-07 |
NO993385D0 (no) | 1999-07-08 |
WO1998031349A1 (de) | 1998-07-23 |
JP2001508070A (ja) | 2001-06-19 |
CA2276445A1 (en) | 1998-07-23 |
CA2276445C (en) | 2005-08-09 |
EP1007014A1 (de) | 2000-06-14 |
DE19700913C2 (de) | 2001-01-04 |
ATE238778T1 (de) | 2003-05-15 |
KR20000070178A (ko) | 2000-11-25 |
JP3821855B2 (ja) | 2006-09-13 |
KR100561255B1 (ko) | 2006-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO993385D0 (no) | Transdermalt terapeutisk system for avgivelse av hormoner | |
ES2054818T3 (es) | Dispositivo mejorado para el suministro transdermal de farmacos. | |
NZ316026A (en) | A transdermal therapeutic system (a hormone patch) in which drugs are contained which are released into the skin comprising a backing film and a pressure sensitive adhesive | |
AU637637B2 (en) | Estrogen-containing active substance plaster | |
NO962933L (no) | Östradiol-penetrasjonsforsterker for transdermal administrering | |
CA2153572A1 (en) | Transdermal therapeutic system with galanthamine as active ingredient | |
EP0177893A3 (en) | Sustained release dosage form based on highly plasticized cellulose ether gels | |
JPS6468314A (en) | Transdermal drug administration system containing two kind of permeation accelerators | |
ZA946698B (en) | Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs | |
YU47956B (sh) | Postupak za izradu transdermalnog terapijskog sistema sa buprenorphinom kao aktivnim sastojkom | |
MY132338A (en) | Estradiol-containing patch | |
CA2338859A1 (en) | Estradiol-containing patch for transdermal administration of hormones | |
ZA901940B (en) | A plaster used as therapeutic system for the administration of active substances to the skin | |
IL106512A (en) | Plaster for the transdermal application of steroid hormones and process for the preparation thereof | |
IL133762A0 (en) | Transdermal therapeutic system (tts) for the administration of levonorgestral | |
PT904067E (pt) | Dextrometorfan como agente antitussico administrado transdermicamente | |
NO20000814L (no) | Identifikasjon for klebende flateformede dermale og transdermale terapeutiske administrasjonsformer under anvendelse av et klebende plaster som informasjonsbærer, såvel som fremgangsmåte for deres fremstilling | |
DE69423616D1 (de) | Molekulares transdermales transportsystem | |
YU71293A (sh) | Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu | |
BR9912688A (pt) | Emplastro contendo estradiol para aplicaçãotransdérmica de hormÈnios | |
AR029664A1 (es) | Parche portador de estrngenos con reservorio de sustancia activa a base de etilcelulosa y un copolemero de etileno, acetato de vinilo y vinilpirrolidona | |
PL332035A1 (en) | Transdermal therapeutic system including an estriol-containing composition of active substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |